GFM
CABA icon

GF Fund Management’s Cabaletta Bio CABA Stock Holding History

GF Fund Management’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10K Buy
3,223
+1,074
+50% +$3.53K ﹤0.01% 537
2026
Q1 		$5.78K Buy
2,149
+258
+14% +$716 ﹤0.01% 599
2025
Q4 		$4.14K Buy
+1,891
New +$4.69K ﹤0.01% 627

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

GF Fund Management's CABA Position: Q2 2026 in Review

GF Fund Management increased its Cabaletta Bio (CABA) stake by 50% in Q2 2026, buying an estimated $3.53K and bringing the position to 3,223 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #537.

GF Fund Management first reported a position in CABA in Q4 2025 and has held it in 3 quarters since. 140 funds tracked by Wall St. Rank hold CABA as of Q2 2026.

  • GF Fund Management held 3,223 shares of Cabaletta Bio worth $10K as of Q2 2026.
  • GF Fund Management bought 1,074 Cabaletta Bio shares in Q2 2026, an estimated $3.53K.
  • Cabaletta Bio made up ﹤0.01% of GF Fund Management's portfolio in Q2 2026, its #537 holding.
  • GF Fund Management first reported a position in Cabaletta Bio in Q4 2025 and has held it in 3 quarters since.
  • 140 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.